Skip to content

Study · Measured the body's own peptide · 2005

1 result

Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus.

Qiu DL, Chu CP, Tsukino H, Shirasaka T, Nakao H, Kato K, Kunitake T, Katoh T, Kannan H

Neuroscience letters1 Feb 2005Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In rat paraventricular nucleus, 82% of neuromedin U-sensitive neurons expressed oxytocin mRNA.

    In plain wordsIn rats, most neurons that respond to neuromedin U (82%) made the body's own oxytocin messenger RNA.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin mRNA in NMU-sensitive PVN neurons
    Study

    ratn = 23

    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Measurements

    Neurons expressing OT mRNA
    82%
    NMU-sensitive PVN neurons

    Source sentences

    Summary
    Of the NMU-sensitive neurons (n=23), 82% expressed OT mRNA, 9% expressed VP mRNA, 9% did not express the detected specific phenotypes mRNA.
    1 context sentence
    Summary · context
    We have characterized the neuromedin U (NMU)-sensitive neurons in the rat paraventricular nucleus (PVN) using whole-cell patch-clamp recordings and single-cell reverse transcription-multiplex polymerase chain reaction (single-cell RT-mPCR).

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.